文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

多组分脓毒症过渡与康复项目对脓毒症后死亡率和再入院的影响:改善脓毒症急性期后照护过渡期发病率随机临床试验

Effect of a Multicomponent Sepsis Transition and Recovery Program on Mortality and Readmissions After Sepsis: The Improving Morbidity During Post-Acute Care Transitions for Sepsis Randomized Clinical Trial.
PubMed 文献 · Crit Care Med · 2022-01-01
一句话结论脓毒症住院高危患者接受护士导航员主导的30天过渡与康复项目,校正后30天死亡或再入院复合终点风险显著降低(aOR 0.80,95%CI 0.64-0.98)。

该多中心实用随机临床试验纳入3家医院691例因疑似脓毒症住院且经内部风险模型判定为死亡或再入院高危的患者,随机分为常规照护组(n=342)和额外脓毒症过渡与康复项目组(n=349)。干预由护士导航员通过电话和电子健康记录沟通,在住院期间及出院后30天内实施出院后药物审查、新发功能障碍或症状评估、合并症监测及适当时姑息治疗等措施,并由医院医学过渡服务团队提供临床监督。主要终点为30天死亡或再入院的复合终点,干预组28.7% vs 常规组33.3%(风险差4.7%;OR 0.80,95%CI 0.58-1.11;校正OR 0.80,95%CI 0.64-0.98)。结论认为该30天项目可降低脓毒症出院后30天内死亡或再入院比例,但需进一步研究成功实施的情境因素。

要点

  • 纳入标准:因疑似脓毒症住院,且经验证的内部风险模型判定为死亡或再入院高危的患者。
  • 干预组30天复合终点(死亡或再入院)发生率为28.7%,常规组为33.3%,风险差4.7%。
  • 未校正OR为0.80(95%CI 0.58-1.11),校正年龄、合并症和入组时器官功能障碍后aOR为0.80(95%CI 0.64-0.98)。
  • 干预组死亡33例(9.5%)vs 常规组41例(12.0%);再入院71例(20.3%)vs 84例(24.6%)。
  • 干预为护士导航员主导的30天过渡服务,包括出院后药物审查、新发功能障碍或症状评估、合并症监测及适当时姑息治疗。

适用人群与场景

  • 因疑似脓毒症住院且经验证的内部风险模型判定为死亡或再入院高危的成人患者(平均年龄63.7±15.1岁,52%女性)。
  • 研究在3家医院开展,干预覆盖住院期间及出院后30天过渡期。

诊断标准与关键阈值

  • 疑似脓毒症住院:原文未提及具体诊断标准或评分界值。
  • 高危判定:使用验证的内部风险模型评估死亡或再入院风险。

处置流程与药物剂量

  • 第一步:由护士导航员通过电话和电子健康记录沟通,在住院期间及出院后30天内提供多组分过渡服务。
  • 第二步:实施出院后药物审查、新发功能障碍或症状评估、合并症监测,适当时采用姑息治疗方法。
  • 第三步:由医院医学过渡服务团队提供临床监督。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心实用随机临床试验,纳入3家医院691例患者,随机分为常规照护组(n=342)和干预组(n=349)。
  • 主要终点为30天死亡或再入院复合终点:干预组28.7% vs 常规组33.3%,风险差4.7%,OR 0.80(95%CI 0.58-1.11),校正OR 0.80(95%CI 0.64-0.98)。
  • 死亡:干预组33例(9.5%)vs 常规组41例(12.0%);再入院:干预组71例(20.3%)vs 常规组84例(24.6%)。
  • 原文未提及关键次要终点的统计学检验结果或不良事件数据。

证据类型、等级与局限

  • 证据类型:多中心实用随机临床试验。
  • 局限:原文未明确提及具体局限;研究仅纳入3家医院,需进一步研究成功实施的情境因素。

对床旁实践的改变

  • 对于因疑似脓毒症住院且经风险模型判定为死亡或再入院高危的患者,可考虑在常规照护基础上增加护士导航员主导的30天过渡与康复项目。
  • 该项目包括出院后药物审查、新发功能障碍或症状评估、合并症监测及适当时姑息治疗,由医院医学过渡服务团队监督。
  • 校正后复合终点风险降低有统计学意义,但未校正OR的95%CI跨1,需结合具体临床情境审慎应用。

指南或共识出处

  • 原文未提及指南或共识名称;研究发表于Crit Care Med。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate whether a nurse navigator-led, multicomponent Sepsis Transition And Recovery program improves 30-day mortality and readmission outcomes after sepsis hospitalization.

DESIG: n: Multisite pragmatic randomized clinical trial.

SETTING: Three hospitals in North Carolina from January 2019 to March 2020.

PATIENTS: Eligible patients hospitalized for suspected sepsis and deemed high-risk for mortality or readmission by validated internal risk models.

INTERVENTIONS: Patients were randomized to receive usual care alone (i.e., routine transition support, outpatient care; n = 342) or additional Sepsis Transition And Recovery support (n = 349). The 30-day intervention involved a multicomponent transition service led by a nurse navigator through telephone and electronic health record communication to facilitate best practice postsepsis care strategies during and after hospitalization including: postdischarge medication review, evaluation for new impairments or symptoms, monitoring comorbidities, and palliative care approach when appropriate. Clinical oversight was provided by a Hospital Medicine Transition Services team.

MEASUREMENTS AND MAIN RESULTS: The primary outcome was a composite of mortality or hospital readmission at 30 days. Logistic regression models were constructed to evaluate marginal and conditional odds ratios (adjusted for prognostic covariates: age, comorbidity, and organ dysfunction at enrollment). Among 691 randomized patients (mean age = 63.7 ± 15.1 yr; 52% female), a lower percentage of patients in the Sepsis Transition And Recovery group experienced the primary outcome compared with the usual care group (28.7% vs 33.3%; risk difference, 4.7%; odds ratio, 0.80; 95% CI, 0.58-1.11; adjusted odds ratio, 0.80; 95% CI, 0.64-0.98). There were 74 deaths (Sepsis Transition And Recovery: 33 [9.5%] vs usual care: 41 [12.0%]) and 155 rehospitalizations (Sepsis Transition And Recovery: 71 [20.3%] vs usual care: 84 [24.6%]).

CONCLUSIONS: In a multisite randomized clinical trial of patients hospitalized with sepsis, patients provided with a 30-day program using a nurse navigator to provide best practices for postsepsis care experienced a lower proportion of either mortality or rehospitalization within 30 days after discharge. Further research is needed to understand the contextual factors associated with successful implementation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Taylor SP, Murphy S, Rios A, et al. Effect of a Multicomponent Sepsis Transition and Recovery Program on Mortality and Readmissions After Sepsis: The Improving Morbidity During Post-Acute Care Transitions for Sepsis Randomized Clinical Trial. Crit Care Med. 2022. PMID: 34534130. doi:10.1097/CCM.0000000000005300

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。